Atrial Fibrillation, Pharmacology and Pharmacotherapy
John Eikelboom, MBBS, MSc, FRCPC is Professor, Department of Medicine, McMaster University; Senior Investigator, Population Health Research Institute; and Haematologist at the Hamilton General Hospital, Ontario, Canada. He holds a Heart and Stroke Foundation Career Award and the Jack Hirsh/Population Health Research Institute Chair in Thrombosis and Atherosclerosis. His research funded by peer-reviewed grants from the Heart and Stroke Foundation, Canadian Institutes for Health Research, and the National Health and Medical Research Council of Australia focuses on novel approaches to preventing and treating thromboembolism and bleeding. Dr Eikelboom has co-authored more than 600 articles in peer-reviewed journals, and since 2014 has been listed annually among the top 1% of the most cited researchers globally in Clinical Medicine.
ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.
Our mission: To reduce the burden of cardiovascular disease